Matches in Wikidata for { <http://www.wikidata.org/entity/Q37314494> ?p ?o ?g. }
- Q37314494 description "article científic" @default.
- Q37314494 description "article scientifique" @default.
- Q37314494 description "articolo scientifico" @default.
- Q37314494 description "artigo científico" @default.
- Q37314494 description "artículu científicu espublizáu en 2016" @default.
- Q37314494 description "bilimsel makale" @default.
- Q37314494 description "scientific article published on September 2016" @default.
- Q37314494 description "vedecký článok" @default.
- Q37314494 description "vetenskaplig artikel" @default.
- Q37314494 description "videnskabelig artikel" @default.
- Q37314494 description "vědecký článek" @default.
- Q37314494 description "wetenschappelijk artikel" @default.
- Q37314494 description "wissenschaftlicher Artikel" @default.
- Q37314494 description "наукова стаття, опублікована у вересні 2016" @default.
- Q37314494 description "научни чланак" @default.
- Q37314494 description "գիտական հոդված հրատարակված 2016 թվականի սեպտեմբերին" @default.
- Q37314494 description "مقالة علمية نشرت في سبتمبر 2016" @default.
- Q37314494 name "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 name "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 name "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 type Item @default.
- Q37314494 label "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 label "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 label "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 prefLabel "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 prefLabel "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 prefLabel "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty." @default.
- Q37314494 P1433 Q37314494-5DB3530A-B766-422E-A3C1-DCE0ABA34B4A @default.
- Q37314494 P1476 Q37314494-D09ED2E6-5D7F-486C-8936-BD18C766AD11 @default.
- Q37314494 P2093 Q37314494-2FA491C4-1023-4069-A97C-38DF2129F18D @default.
- Q37314494 P2093 Q37314494-74AD9204-0727-4A4C-B8DF-3A8D9D808C9C @default.
- Q37314494 P2093 Q37314494-BACEEB6D-4518-46A3-AAFE-07D811DDD684 @default.
- Q37314494 P2093 Q37314494-E0BA57E3-A319-4A8A-BBF7-D36E84BFE234 @default.
- Q37314494 P2860 Q37314494-0667383D-7035-4863-BCD6-885F8B0357C8 @default.
- Q37314494 P2860 Q37314494-276360E9-7803-4227-B004-C310E709CFEA @default.
- Q37314494 P2860 Q37314494-2A3E17BE-DADE-4F67-9D16-E238FE80D19F @default.
- Q37314494 P2860 Q37314494-37B7DECC-953D-46A7-9524-0A2A051D5DB0 @default.
- Q37314494 P2860 Q37314494-3D3F7104-3314-4EB1-A7A5-DFD9E94705F4 @default.
- Q37314494 P2860 Q37314494-496F19D5-9D71-41ED-90C1-1DBD3A82E477 @default.
- Q37314494 P2860 Q37314494-4D439E13-1301-47C1-8221-4A9001B1A0C9 @default.
- Q37314494 P2860 Q37314494-4FE02899-AD3B-4B2D-A2F6-CE39F021A594 @default.
- Q37314494 P2860 Q37314494-4FF3780E-7CA8-40F9-8D97-5D43E9204AD9 @default.
- Q37314494 P2860 Q37314494-59038186-3342-43E4-8CCA-DE1DB5DB5A21 @default.
- Q37314494 P2860 Q37314494-62A67490-C7F0-449C-B094-D230D331AA47 @default.
- Q37314494 P2860 Q37314494-646B73B8-9C89-4E19-B8D2-A13975A41295 @default.
- Q37314494 P2860 Q37314494-67062233-7E7E-4699-9F09-E5C52BEC15A4 @default.
- Q37314494 P2860 Q37314494-790BB3EA-BF53-4B4E-95A3-4700663BA117 @default.
- Q37314494 P2860 Q37314494-7FC0E2B8-2B1C-4662-A74C-E144832FBB53 @default.
- Q37314494 P2860 Q37314494-88987F29-4411-4D7B-A905-81B88D2F56DE @default.
- Q37314494 P2860 Q37314494-899CAE03-4C8B-4F49-A040-FC7ECD107832 @default.
- Q37314494 P2860 Q37314494-8B42CD5B-D53E-4374-A1A2-B5563FE317AB @default.
- Q37314494 P2860 Q37314494-BEDA01E4-47C8-48BB-813D-BA3C5865805A @default.
- Q37314494 P2860 Q37314494-BFE8440C-C29D-47A7-97FC-56D54D89CEFD @default.
- Q37314494 P2860 Q37314494-C39B8287-0A83-49F5-86AF-1E4D29602986 @default.
- Q37314494 P2860 Q37314494-CC5C38A4-39A2-4E7E-924D-E4174E6F5ACE @default.
- Q37314494 P2860 Q37314494-CD9BC07A-63F7-4E6B-8E34-94086D3DC186 @default.
- Q37314494 P2860 Q37314494-D2176BBA-6CFE-4B32-9812-51CF03C07427 @default.
- Q37314494 P2860 Q37314494-D86F8DF8-BA06-4EC1-820E-4D4305AB88EF @default.
- Q37314494 P2860 Q37314494-DEAFCF97-14DA-4E4E-BE52-5A31A689767A @default.
- Q37314494 P2860 Q37314494-EE1315DD-B20F-4035-A4A2-D44239658743 @default.
- Q37314494 P304 Q37314494-A9F2B98F-7C56-4E92-8478-406C4D349093 @default.
- Q37314494 P31 Q37314494-4D44C3AA-9F70-4E46-85F1-B92349820C0D @default.
- Q37314494 P356 Q37314494-7739E1DE-C8DE-4CA8-A9CA-86E0EE8D3D5B @default.
- Q37314494 P433 Q37314494-BFEEE848-9811-4C20-A0C9-49D204A1E845 @default.
- Q37314494 P478 Q37314494-B9F7170B-73FA-49CA-BAD2-996E2E54D2FD @default.
- Q37314494 P577 Q37314494-5C19DD24-5635-4135-BB8A-AA69EE43F0DE @default.
- Q37314494 P698 Q37314494-810A9B8B-8D88-44FB-912D-BD6B0C44BE4B @default.
- Q37314494 P921 Q37314494-1AFCEFFB-A165-461F-9E83-F11E00F99C4A @default.
- Q37314494 P921 Q37314494-2D0B4218-E456-42EA-ADAF-88510A3ABCD0 @default.
- Q37314494 P921 Q37314494-451F8650-90E2-4703-A79E-AEF081FEF7E9 @default.
- Q37314494 P921 Q37314494-9B6D2892-0775-4D05-9D39-CB072257F04F @default.
- Q37314494 P932 Q37314494-F26D6572-DAD3-4584-8FFD-B5FD6C096345 @default.
- Q37314494 P356 ACS20150731D @default.
- Q37314494 P698 27713601 @default.
- Q37314494 P1433 Q2366246 @default.
- Q37314494 P1476 "Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty" @default.
- Q37314494 P2093 "Chao-Chin Yu" @default.
- Q37314494 P2093 "I-Chih Chen" @default.
- Q37314494 P2093 "Ting-Hsing Chao" @default.
- Q37314494 P2093 "Yi-Hsuan Wu" @default.
- Q37314494 P2860 Q26828369 @default.
- Q37314494 P2860 Q26852048 @default.
- Q37314494 P2860 Q34182626 @default.
- Q37314494 P2860 Q36652294 @default.
- Q37314494 P2860 Q37379663 @default.
- Q37314494 P2860 Q37889303 @default.
- Q37314494 P2860 Q38082646 @default.
- Q37314494 P2860 Q38171938 @default.
- Q37314494 P2860 Q38328898 @default.
- Q37314494 P2860 Q38971066 @default.
- Q37314494 P2860 Q39156053 @default.
- Q37314494 P2860 Q39279099 @default.
- Q37314494 P2860 Q41481520 @default.
- Q37314494 P2860 Q44101560 @default.
- Q37314494 P2860 Q44797515 @default.
- Q37314494 P2860 Q45343724 @default.
- Q37314494 P2860 Q46128340 @default.
- Q37314494 P2860 Q46228296 @default.
- Q37314494 P2860 Q46434149 @default.
- Q37314494 P2860 Q54262991 @default.